Ann Childress, MD

A panelist discusses how attention deficit/hyperactivity disorder (ADHD) as a common neurodevelopmental disorder characterized by inattention and hyperactive-impulsive behavior, affecting approximately 10.5% of children in the US aged 3 to 17 years with higher prevalence in adolescents and boys, highlighting its various symptoms, potential causes including genetic factors, and mentioning upcoming discussions about treatment options and transitioning care from pediatric to adult settings.

Ann Childress, MD, the current president of APSARD, invites you to attend this year's conference!

New positive data for novel ADHD treatment.

This new medication is a huge leap forward for treating attention-deficit/hyperactivity disorder.